TEAM Technologies (“TEAM Tech”), a leading end-to-end outsourced manufacturer of mission-critical medical devices, announces the acquisition of TAG3 Engineering LLC (“TAG3” or the “Company”), a full-service MedTech design, development, and manufacturing firm located in Sunrise, Florida. TAG3 brings expanded U.S.-based front end innovation capabilities to TEAM Tech’s portfolio of specialty manufacturing solutions for the medical device industry.
Offering expertise across every phase of the development of medical devices including front end design, engineering, regulatory, verification and validation (V&V) testing, and manufacturing, TAG3 ensures that devices meet and exceed the stringent industry standards of the medical device industry. “We pride ourselves on our ability to help our customers, from physicians and entrepreneurs to large OEM medical device companies, conceptualize an idea and guide them through the entire process of bringing it to life. We are thrilled to be part of TEAM Tech, an organization that shares our values, commitment to innovation, and excellence in medical technology,” commented Victor Gamez, one of the Founders of TAG3 Engineering.
“TAG3’s medical device development and front-end innovation capabilities dovetail well with TEAM Tech’s existing core capabilities of taking an idea from concept and scaling it to commercialization,” stated Marshall White, President and CEO at TEAM Tech. “With these added capabilities, we are even better positioned to provide exceptional value to healthcare OEMs, and we are thrilled to welcome TAG3 to TEAM Tech,” he added.
Matt Altman, a Managing Partner at Arlington Capital Partners, said, “The acquisition of TAG3 further enhances TEAM Tech’s fast-growing minimally invasive surgical franchise. We are excited to partner with the exceptional TAG3 team to further support our healthcare customers from innovative design all the way through commercial production.”
TAG3’s product and design experience includes the following therapeutic areas:
- Cardiovascular
- Neurovascular
- Structural Heart
- Peripheral Vascular
- Stroke
- Glaucoma
- Gastrointestinal
- Urological
Compliance at every stage of device development is supported through TAG3’s ISO 13485-certified and FDA 21 Part 820-compliant quality system. The TAG3 GMP-compliant facility features Class 7 and Class 8 Clean Rooms, testing and simulation labs, 3D printing, and electrospinning equipment.
Solomon Partners served as financial advisor to TEAM Tech. Bonifacio Consulting Services (BCS) served as operational advisor to TEAM Tech.
